Suvoda

Suvoda

Barcelona, Spain· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $35M

Overview

Suvoda is a private, revenue-generating digital health company founded in 2013 and headquartered in Barcelona, Spain. It offers a unified, patented platform that integrates eight core products—including IRT, eCOA, eConsent, and patient financial solutions—to simplify operational challenges in clinical trials, particularly in high-stakes therapeutic areas like oncology, rare disease, and CNS. Backed by expert client services, Suvoda supports over 2,000 trials across 95+ countries, positioning itself as a trusted operational partner for the life sciences industry.

OncologyRare DiseaseCNS

Technology Platform

A unified, real-time software platform for clinical trial execution. It integrates eight modular products: IRT (Interactive Response Technology), eCOA (electronic Clinical Outcome Assessments), eConsent, Greenphire Patient Payments, Greenphire Travel Scheduling, a Patient App, Site Payments, and Budgeting & Benchmarking. The platform is designed to synchronize data and activity across sponsors, CROs, sites, and patients, streamlining complex trial workflows.

Funding History

2
Total raised:$35M
Series B$25M
Series A$10M

Opportunities

The growing adoption of decentralized and patient-centric trial models creates demand for integrated platforms that handle logistics, payments, and data collection.
Suvoda's deep specialization in complex therapeutic areas (oncology, rare disease) offers a defensible niche with high value per trial.
The full integration of Greenphire's financial tools presents a unique, comprehensive solution for clinical trial financial lifecycle management.

Risk Factors

Failure to successfully integrate acquired Greenphire technology and teams could disrupt service and erode client trust.
The company faces intense competition from larger, well-funded clinical tech platforms and must continuously innovate.
Revenue is susceptible to downturns in biopharma R&D spending, particularly in its core, high-cost therapeutic areas.

Competitive Landscape

Suvoda competes in the fragmented clinical trial technology market against large enterprise vendors like Veeva Systems and Medidata (a Dassault Systèmes company), as well as numerous best-of-breed point solution providers in IRT, eCOA, and patient convenience. Its key differentiator is the depth of integration across its eight modules, its focus on critical trial moments, and its specialized expertise in complex disease trials.